{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:02:42Z","timestamp":1789581762493,"version":"build-2803163510"},"reference-count":50,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2026,9,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dyspnoea is a prevalent, debilitating symptom in advanced life-limiting illnesses. While opioids and non-pharmacological measures remain foundational, refractory breathlessness presents a major palliative challenge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To critically appraise the evidence regarding patient selection, comparative tolerability, adverse effects and ethical considerations of non-invasive ventilation (NIV) and high-flow nasal therapy (HFNT) in palliative care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive narrative review of literature from PubMed, Embase and Cochrane Library (from inception to June 2026) and major clinical guidelines was conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>NIV is best supported in hypercapnic respiratory failure (PaCO &gt;45 mm\u2009Hg), showing benefits in chronic obstructive pulmonary disease exacerbations, pulmonary oedema and amyotrophic lateral sclerosis (ALS). In advanced cancer, NIV reduces dyspnoea primarily in hypercapnic patients but mask discomfort and communication barriers limit tolerability. Conversely, HFNT has emerged as a superiorly tolerated option in hypoxemic failure\u2014particularly in end-stage interstitial lung disease (ILD) and advanced cancer\u2014providing significant dyspnoea relief while preserving oral intake and verbal communication until the end of life. Time-limited trials (&lt;1 hour for NIV; 2 hours for HFNT) help identify early responders. Ethical challenges include potential overtreatment and support withdrawal complexities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Respiratory support selection should be guided by respiratory physiology (hypercapnic vs hypoxemic), explicit goals of care and tolerability. NIV remains optimal for hypercapnic failure, whereas HFNT offers superior comfort and preserves communication in hypoxaemic patients. Robust randomised trials are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/spcare-2026-006580","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:20:17Z","timestamp":1789579217000},"page":"spcare-2026-006580","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Non-invasive ventilation (NIV) and high-flow nasal therapy (HFNT) in palliative care: a critical narrative review"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9859-6487","authenticated-orcid":false,"given":"Sebastiano","family":"Mercadante","sequence":"first","affiliation":[{"name":"Pain Relief and Supportive Care, Casa di Cura La Maddalena SpA, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"2026091610201102000_spcare-2026-006580v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70009-3"},{"key":"2026091610201102000_spcare-2026-006580v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2009.09.017"},{"key":"2026091610201102000_spcare-2026-006580v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2005.06.007"},{"key":"2026091610201102000_spcare-2026-006580v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61115-4"},{"key":"2026091610201102000_spcare-2026-006580v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2009.09.024"},{"key":"2026091610201102000_spcare-2026-006580v1.6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02426-2016","article-title":"Official ERS\/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure","volume":"50","author":"Rochwerg","year":"2017","journal-title":"Eur Respir J"},{"key":"2026091610201102000_spcare-2026-006580v1.7","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-016-1263-z","article-title":"Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failure","volume":"20","author":"Roca","year":"2016","journal-title":"Crit Care"},{"key":"2026091610201102000_spcare-2026-006580v1.8","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.20.03465","article-title":"Management of Dyspnea in Advanced Cancer: ASCO Guideline","volume":"39","author":"Hui","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026091610201102000_spcare-2026-006580v1.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-001-1114-4"},{"key":"2026091610201102000_spcare-2026-006580v1.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7382.185"},{"key":"2026091610201102000_spcare-2026-006580v1.11","article-title":"Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease","volume":"7","author":"Osadnik","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026091610201102000_spcare-2026-006580v1.12","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2026 report. GOLD; 2026."},{"key":"2026091610201102000_spcare-2026-006580v1.13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jamainternmed.2020.5640","article-title":"Trends in Noninvasive and Invasive Mechanical Ventilation Among Medicare Beneficiaries at the End of Life","volume":"181","author":"Sullivan","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2026091610201102000_spcare-2026-006580v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70326-4"},{"key":"2026091610201102000_spcare-2026-006580v1.15","article-title":"Mechanical ventilation for amyotrophic lateral sclerosis\/motor neuron disease","volume":"10","author":"Radunovic","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026091610201102000_spcare-2026-006580v1.16","first-page":"1524","article-title":"Monitoring and management of home noninvasive ventilation users: an official CHEST guideline","volume":"164","author":"Rose","year":"2023","journal-title":"Chest"},{"key":"2026091610201102000_spcare-2026-006580v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70221-2"},{"key":"2026091610201102000_spcare-2026-006580v1.18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jpainsymman.2012.10.284","article-title":"High-flow oxygen and bilevel positive airway pressure for persistent dyspnea in patients with advanced cancer: a phase II randomized trial","volume":"46","author":"Hui","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"2026091610201102000_spcare-2026-006580v1.19","first-page":"45","article-title":"High-flow nasal cannula for dyspnea in cancer patients: a systematic review and meta-analysis","volume":"34","author":"Hentsch","year":"2026","journal-title":"Support Care Cancer"},{"key":"2026091610201102000_spcare-2026-006580v1.20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.annemergmed.2019.09.009","article-title":"High-Flow Nasal Cannula Versus Conventional Oxygen Therapy in Relieving Dyspnea in Emergency Palliative Patients With Do-Not-Intubate Status: A Randomized Crossover Study","volume":"75","author":"Ruangsomboon","year":"2020","journal-title":"Ann Emerg Med"},{"key":"2026091610201102000_spcare-2026-006580v1.21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000489890","article-title":"Efficacy and Tolerability of High-Flow Nasal Cannula Oxygen Therapy for Hypoxemic Respiratory Failure in Patients with Interstitial Lung Disease with Do-Not-Intubate Orders: A Retrospective Single-Center Study","volume":"96","author":"Koyauchi","year":"2018","journal-title":"Respiration"},{"key":"2026091610201102000_spcare-2026-006580v1.22","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215917"},{"key":"2026091610201102000_spcare-2026-006580v1.23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpainsymman.2023.11.009","article-title":"A Phase II Study of High-Flow Nasal Cannula for Relieving Dyspnea in Advanced Cancer Patients","volume":"67","author":"Takase","year":"2024","journal-title":"J Pain Symptom Manage"},{"key":"2026091610201102000_spcare-2026-006580v1.24","doi-asserted-by":"crossref","first-page":"e1470","DOI":"10.1002\/onco.13624","article-title":"High-Flow Nasal Cannula Therapy for Exertional Dyspnea in Patients with Cancer: A Pilot Randomized Clinical Trial","volume":"26","author":"Hui","year":"2021","journal-title":"Oncologist"},{"key":"2026091610201102000_spcare-2026-006580v1.25","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202201-0199OC"},{"key":"2026091610201102000_spcare-2026-006580v1.26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4187\/respcare.09540071","article-title":"Interfaces and humidification for noninvasive mechanical ventilation","volume":"54","author":"Nava","year":"2009","journal-title":"Respir Care"},{"key":"2026091610201102000_spcare-2026-006580v1.27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.22343"},{"key":"2026091610201102000_spcare-2026-006580v1.28","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00051604"},{"key":"2026091610201102000_spcare-2026-006580v1.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.08.004"},{"key":"2026091610201102000_spcare-2026-006580v1.30","first-page":"171","article-title":"High-flow nasal cannula oxygen therapy for acute respiratory failure in patients with interstitial lung disease: a multicenter study","volume":"61","author":"Kim","year":"2023","journal-title":"Respir Investig"},{"key":"2026091610201102000_spcare-2026-006580v1.31","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.04577"},{"key":"2026091610201102000_spcare-2026-006580v1.32","unstructured":"Cochrane Database of Systematic Reviews . Defined by Cochrane review on HFNC for respiratory support. 2023."},{"key":"2026091610201102000_spcare-2026-006580v1.33","first-page":"1295","article-title":"High-flow nasal cannula therapy in pediatric and neonatal patients","volume":"66","author":"Narang","year":"2021","journal-title":"Respir Care"},{"key":"2026091610201102000_spcare-2026-006580v1.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.aucc.2007.08.001"},{"key":"2026091610201102000_spcare-2026-006580v1.35","first-page":"2401234","article-title":"Nasal high flow in fibrotic interstitial lung disease: a physiological study","volume":"67","author":"Thivent","year":"2026","journal-title":"Eur Respir J"},{"key":"2026091610201102000_spcare-2026-006580v1.36","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06459-2"},{"key":"2026091610201102000_spcare-2026-006580v1.37","unstructured":"National Comprehensive Cancer Network (NCCN) . Palliative care. NCCN clinical practice guidelines in oncology. Version 2. 2026."},{"key":"2026091610201102000_spcare-2026-006580v1.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.04.007"},{"key":"2026091610201102000_spcare-2026-006580v1.39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jointm.2024.10.005","article-title":"Physiological effects and clinical evidence of high-flow nasal cannula during acute exacerbation in COPD patients: A narrative review","volume":"5","author":"Colaianni-Alfonso","year":"2025","journal-title":"J Intensive Med"},{"key":"2026091610201102000_spcare-2026-006580v1.40","first-page":"9093","article-title":"Effect of heated humidified high-flow nasal cannula (HFNC) oxygen therapy in dyspnea patients with advanced cancer, a randomized controlled clinical trial","volume":"30","author":"Xu","year":"2022","journal-title":"Support Care Cancer"},{"key":"2026091610201102000_spcare-2026-006580v1.41","first-page":"12","article-title":"SPOT-ON: a personalized randomized clinical trial of supplemental oxygen, high-flow nasal cannula, and noninvasive ventilation for dyspnea in advanced cancer","volume":"24","author":"Hui","year":"2025","journal-title":"BMC Palliat Care"},{"key":"2026091610201102000_spcare-2026-006580v1.42","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202006-2382ST"},{"key":"2026091610201102000_spcare-2026-006580v1.43","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-022-02142-4","article-title":"Retraction Note: Long non-coding RNA GATA6-AS1 upregulates GATA6 to regulate the biological behaviors of lung adenocarcinoma cells","volume":"22","author":"Kang","year":"2022","journal-title":"BMC Pulm Med"},{"key":"2026091610201102000_spcare-2026-006580v1.44","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/CCM.0000000000003082","article-title":"Noninvasive Ventilation in Patients With Do-Not-Intubate and Comfort-Measures-Only Orders: A Systematic Review and Meta-Analysis","volume":"46","author":"Wilson","year":"2018","journal-title":"Crit Care Med"},{"key":"2026091610201102000_spcare-2026-006580v1.45","first-page":"479","article-title":"Quality measures in amyotrophic lateral sclerosis: a scoping review","volume":"23","author":"Carvalho","year":"2022","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2026091610201102000_spcare-2026-006580v1.46","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-312606"},{"key":"2026091610201102000_spcare-2026-006580v1.47","first-page":"45","article-title":"Healthcare professionals\u2019 experiences of elective withdrawal of non-invasive ventilation in motor neurone disease: a qualitative study","volume":"15","author":"Cox","year":"2025","journal-title":"BMJ Support Palliat Care"},{"key":"2026091610201102000_spcare-2026-006580v1.48","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-089617","article-title":"National review of end-of-life care withdrawal guidelines for non-invasive advanced respiratory support using document analysis","volume":"14","author":"Wenzel","year":"2024","journal-title":"BMJ Open"},{"key":"2026091610201102000_spcare-2026-006580v1.49","first-page":"267","article-title":"High-flow nasal cannula in interstitial lung disease-related respiratory failure: a systematic review","volume":"30","author":"Pagliaro","year":"2024","journal-title":"Pulmonology"},{"key":"2026091610201102000_spcare-2026-006580v1.50","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2147\/COPD.S206111","article-title":"Nasal high-flow versus noninvasive ventilation in patients with chronic hypercapnic COPD","volume":"14","author":"Br\u00e4unlich","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2026-006580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:20:24Z","timestamp":1789579224000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2026-006580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":50,"alternative-id":["10.1136\/spcare-2026-006580"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2026-006580","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}